Protalix Biotherapeutics Inc - ESG Rating & Company Profile powered by AI
If you are employed by Protalix Biotherapeutics Inc and you wish to licence your Sustainability aseessment, please get in touch. This dashboard includes a questions and answers table for Protalix Biotherapeutics Inc. The Disclosure score covers seventeen UN SDGs including: 'Zero Hunger', 'Decent Work & Economic Growth' and 'Partnerships for the Goals'.
Protalix Biotherapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 1.2; made up of an environmental score of 0.0, social score of 1.6 and governance score of 2.0.
1.2
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1755 | TRACON Pharmaceuticals Inc | 1.3 | Low |
| 1755 | Trimurthi Ltd | 1.3 | Low |
| 1779 | Protalix Biotherapeutics Inc | 1.2 | Low |
| 1779 | Cell Biotech Co Ltd | 1.2 | Low |
| 1779 | Aurisco Pharmaceutical Co Ltd | 1.2 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Protalix Biotherapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Protalix Biotherapeutics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Protalix Biotherapeutics Inc report the average age of the workforce?
Sign up for free to unlockDoes Protalix Biotherapeutics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Protalix Biotherapeutics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Protalix Biotherapeutics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Protalix Biotherapeutics Inc offer flexible work?
Sign up for free to unlockDoes Protalix Biotherapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Protalix Biotherapeutics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Protalix Biotherapeutics Inc conduct supply chain audits?
Sign up for free to unlockDoes Protalix Biotherapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Protalix Biotherapeutics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Protalix Biotherapeutics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Protalix Biotherapeutics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Protalix Biotherapeutics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Protalix Biotherapeutics Inc disclose water use targets?
Sign up for free to unlockDoes Protalix Biotherapeutics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Protalix Biotherapeutics Inc have a product recall in the last two years?
Sign up for free to unlockDoes Protalix Biotherapeutics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Protalix Biotherapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Protalix Biotherapeutics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Protalix Biotherapeutics Inc disclose parental leave metrics?
Sign up for free to unlockDoes Protalix Biotherapeutics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Protalix Biotherapeutics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Protalix Biotherapeutics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Protalix Biotherapeutics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Protalix Biotherapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Protalix Biotherapeutics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Protalix Biotherapeutics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Protalix Biotherapeutics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Protalix Biotherapeutics Inc disclose its waste policy?
Sign up for free to unlockDoes Protalix Biotherapeutics Inc report according to TCFD requirements?
Sign up for free to unlockDoes Protalix Biotherapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Protalix Biotherapeutics Inc disclose energy use targets?
Sign up for free to unlockDoes Protalix Biotherapeutics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Protalix Biotherapeutics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Protalix Biotherapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso for the treatment of Gaucher disease. Its product pipeline comprises PRX-102, a therapeutic protein candidate, which is in the last stage of clinical trials for the treatment of Fabry diseases; PRX-110, a proprietary plant cell recombinant form of human deoxyribonuclease I that has completed phase IIa clinical trials for the treatment of cystic fibrosis; PRX-115, a plant cell-expressed recombinant PEGylated Uricase for the treatment of gout; and PRX-119, a plant cell-expressed PEGylated recombinant human DNase I product candidate for the treatment of NETs-related diseases. The company has agreements and partnerships with Pfizer; Fundação Oswaldo Cruz (Fiocruz); and Chiesi Farmaceutici S.p.A. The company was founded in 1993 and is based in Hackensack, New Jersey.